RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Integral Diagnostics Stock

Integral Diagnostics Net Income 2024

Integral Diagnostics Net Income

17.48 M AUD

Ticker

IDX.AX

ISIN

AU000000IDX2

In 2024, Integral Diagnostics's profit amounted to 17.48 M AUD, a -30.18% increase from the 25.04 M AUD profit recorded in the previous year.

The Integral Diagnostics Net Income history

YEARNET INCOME (undefined AUD)
2029e65.23
2028e51.93
2027e44.42
2026e32.96
2025e25.12
2024e17.48
202325.04
202214.6
202131.27
202023.03
201920.98
201815.08
201715.48
201611.39
20154.5
20146.1
20134.9

Integral Diagnostics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Integral Diagnostics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Integral Diagnostics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Integral Diagnostics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Integral Diagnostics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Integral Diagnostics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Integral Diagnostics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Integral Diagnostics’s growth potential.

Integral Diagnostics Revenue, EBIT and net profit per share

DateIntegral Diagnostics RevenueIntegral Diagnostics EBITIntegral Diagnostics Net Income
2029e680.21 M undefined113.53 M undefined65.23 M undefined
2028e602.92 M undefined83.52 M undefined51.93 M undefined
2027e569.11 M undefined77.61 M undefined44.42 M undefined
2026e539.77 M undefined73.1 M undefined32.96 M undefined
2025e508.77 M undefined60.94 M undefined25.12 M undefined
2024e476.76 M undefined47.07 M undefined17.48 M undefined
2023440.79 M undefined39.83 M undefined25.04 M undefined
2022360.93 M undefined38.62 M undefined14.6 M undefined
2021350.7 M undefined56.07 M undefined31.27 M undefined
2020275.57 M undefined48.67 M undefined23.03 M undefined
2019232.39 M undefined37.87 M undefined20.98 M undefined
2018189.73 M undefined28.64 M undefined15.08 M undefined
2017180.1 M undefined23.87 M undefined15.48 M undefined
2016168.03 M undefined26.59 M undefined11.39 M undefined
2015151.4 M undefined25.11 M undefined4.5 M undefined
201460.6 M undefined10.5 M undefined6.1 M undefined
201351 M undefined10.3 M undefined4.9 M undefined

Integral Diagnostics stock margins

The Integral Diagnostics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Integral Diagnostics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Integral Diagnostics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Integral Diagnostics's sales revenue. A higher gross margin percentage indicates that the Integral Diagnostics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Integral Diagnostics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Integral Diagnostics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Integral Diagnostics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Integral Diagnostics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Integral Diagnostics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Integral Diagnostics Margin History

Integral Diagnostics Gross marginIntegral Diagnostics Profit marginIntegral Diagnostics EBIT marginIntegral Diagnostics Profit margin
2029e95.23 %16.69 %9.59 %
2028e95.23 %13.85 %8.61 %
2027e95.23 %13.64 %7.8 %
2026e95.23 %13.54 %6.11 %
2025e95.23 %11.98 %4.94 %
2024e95.23 %9.87 %3.67 %
202395.23 %9.04 %5.68 %
202294.67 %10.7 %4.05 %
202195.15 %15.99 %8.92 %
202095.47 %17.66 %8.36 %
201995.51 %16.3 %9.03 %
201895.44 %15.09 %7.95 %
201795.09 %13.25 %8.6 %
201695.02 %15.82 %6.78 %
201594.25 %16.58 %2.97 %
201495.54 %17.33 %10.07 %
201396.08 %20.2 %9.61 %

Integral Diagnostics Aktienanalyse

What does Integral Diagnostics do?

Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Integral Diagnostics's Profit Margins

The profit margins of Integral Diagnostics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Integral Diagnostics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Integral Diagnostics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Integral Diagnostics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Integral Diagnostics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Integral Diagnostics stock

How much profit has Integral Diagnostics made this year?

Integral Diagnostics has made 17.48 M AUD this year.

How has the profit developed compared to last year?

The profit has increased by -30.18% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Integral Diagnostics publish its earnings?

Integral Diagnostics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Integral Diagnostics?

The profits of Integral Diagnostics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Integral Diagnostics?

You can learn more about the earnings of Integral Diagnostics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Integral Diagnostics pay?

Over the past 12 months, Integral Diagnostics paid a dividend of 0.09 AUD . This corresponds to a dividend yield of about 3.39 %. For the coming 12 months, Integral Diagnostics is expected to pay a dividend of 0.08 AUD.

What is the dividend yield of Integral Diagnostics?

The current dividend yield of Integral Diagnostics is 3.39 %.

When does Integral Diagnostics pay dividends?

Integral Diagnostics pays a quarterly dividend. This is distributed in the months of October, April, September, March.

How secure is the dividend of Integral Diagnostics?

Integral Diagnostics paid dividends every year for the past 14 years.

What is the dividend of Integral Diagnostics?

For the upcoming 12 months, dividends amounting to 0.08 AUD are expected. This corresponds to a dividend yield of 3.34 %.

In which sector is Integral Diagnostics located?

Integral Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Integral Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Integral Diagnostics from 4/2/2024 amounting to 0.036 AUD, you needed to have the stock in your portfolio before the ex-date on 2/29/2024.

When did Integral Diagnostics pay the last dividend?

The last dividend was paid out on 4/2/2024.

What was the dividend of Integral Diagnostics in the year 2023?

In the year 2023, Integral Diagnostics distributed 0.1 AUD as dividends.

In which currency does Integral Diagnostics pay out the dividend?

The dividends of Integral Diagnostics are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Integral Diagnostics

Our stock analysis for Integral Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integral Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.